Urgent Medical Device Correction: We have initiated a voluntary recall for a small number of FreeStyle Libre 3 sensors that were distributed in the U.S. with lot numbers: T60001948, T60001966 and T60001969. Please visit www.FreeStyleConfirm.com for more info.

See why we're the #1 CGM in the US*.

CGM = continuous glucose monitor(ing)

Man wearing a FreeStyle Libre continuous glucose monitoring (CGM) sensor while sitting on a bench with friends
Man wearing a FreeStyle Libre continuous glucose monitoring (CGM) sensor while sitting on a bench with friends
Man wearing a FreeStyle Libre continuous glucose monitoring (CGM) sensor while sitting on a bench with friends

The FreeStyle Libre systems are designed with you in mind.

  • Strongest, most reliable connectivity†1
  • Easy to wear comfortably2 for up to 15 days
  • Updated readings every minute
  • 5x faster than any other CGMs§3

How do our sensors compare with the Dexcom G7 system?

test

Features

test

 

Dexcom G7 system

Alarms-alertsAlarms/alerts

Yes, real-time alarmsII (based on readings every 1 minute)

Yes, real-time alarms (based on readings every 1 minute)

Yes, real-time alarms (based on readings every 5 minutes)4

ApplicationApplication

No overpatch required—easy to apply2 using a one-piece applicator

No overpatch required—easy to apply#5,6

Requires the use of an overpatch4

Glucose reading frequencyGlucose reading frequency

Every minute7

Every minute8

Every 5 minutes4

AppApp

FreeStyle Libre 3 app**

FreeStyle Libre 2 app††

Dexcom G7 CGM app

Sensor sizeSensor size

Smaller than two stacked pennies1

Same thickness as two stacked quarters1

1.5x thicker than the FreeStyle Libre 3 system1,7

Sensor lifespanSensor lifespan

15 days

15 days

10 days + 12-hour grace period4

Sensor memory storageSensor memory storage

15 days7

8 hours8

24 hours4

Bluetooth rangeBluetooth range

33 feet

20 feet

33 feet4

MBPA or IBOAMBPA or IBOA skin allergens

No‡‡1

No‡‡1

Evidence shows IBOA was found in Dexcom G71,9

 

IBOA = isobornyl acrylate; MBPA = methylenebisphosphonic acid

Start your journey with MyFreeStyle.

When you join MyFreeStyle, you’ll get the support you need to start taking small actions that can add up to big changes over time. Sign up to start receiving emails, texts, and other resources that will help you:

  • Understand the benefits of CGM vs BGM
  • Know how food and exercise affect your glucose levels, so you can make more confident choices1
  • Master FreeStyle Libre systems with helpful tips and tutorials

Affordability

Interested in cost and coverage information?

More people pay $0 for FreeStyle Libre systems than any other CGMs§§1.

Explore cost & coverage details

FreeStyle Libre Apps

Learn more about the apps.

The FreeStyle Libre family of appsIIII allow you to access your glucose data and receive real-time glucose alarms¶¶.

Discover the apps

The FreeStyle Libre 3 system includes the FreeStyle Libre 3 Plus and FreeStyle Libre 3 sensors, FreeStyle Libre 3 app, and the FreeStyle Libre 3 reader.

FreeStyle Libre 3 and FreeStyle Libre 2 systems are indicated for use in people with diabetes ages 4 and older.

Freestyle Libre 2 Plus sensor and 3 Plus sensor are indicated for use in people with diabetes age 2 and older.

Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.

* Based on retail and DME sales data for patient’s last-filled prescription, by manufacturer.

† Based on signal range in Dexcom G7 User Guide and Medtronic Guardian Connect System User Guide.

‡ 60-minute warm-up required when starting the sensor.

§ In comparison with Dexcom G7 and Medtronic Guardian Connect System User Guide.

II Notifications will only be received when alarms are turned on and the sensor is within 33 feet unobstructed of the reading device. You must enable the appropriate settings on your smartphone to receive alarms and alerts, see the FreeStyle Libre 3 User’s Manual for more information.

¶ Notifications will only be received when alarms are turned on and the sensor is within 20 feet unobstructed of the reading device. You must enable the appropriate settings on your smartphone to receive alarms and alerts, see the FreeStyle Libre 2 User’s Manual for more information.

# Data from this study was collected with the outside US version of FreeStyle Libre 14 day system. FreeStyle Libre 2 has the same features as FreeStyle Libre 14 day system with optional, real-time glucose alarms. Therefore, the study data is applicable to both products.

** The FreeStyle Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our compatibility guide for more information about device compatibility before using the app.

†† The FreeStyle Libre 2 app is only compatible with certain mobile devices and operating systems. Please check our compatibility guide for more information about device compatibility before using the app. Use of the FreeStyle Libre 2 app requires registration with LibreView.

‡‡ Not made with these skin allergens. IBOA and MBPA not detected. Test method limit of detection was 0.0016 μg per device for IBOA and 0.0079 μg per device for MBPA.

§§ Based on prescription claims for the aggregate of patients covered by Commercial insurance, Managed Medicare, Managed Medicaid using the FreeStyle Libre personal CGM systems versus competitors’ CGM systems. Does not include fee-for-service Medicare, fee-for-service Medicaid, and uninsured patients. The actual amount a patient pays may vary. The FreeStyle Libre personal CGM systems require a prescription.

IIII The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.

¶¶ Alarm notifications will only be received when alarms settings are enabled and turned on and sensor is within 20 feet (FreeStyle Libre 2) or 33 feet (FreeStyle Libre 3) unobstructed of the reading device.

◊ Eligible patients will receive one (1) FreeStyle Libre 2 system sensor or (1) FreeStyle Libre 3 system sensor for users with a compatible mobile phone operating system at $0 copay. The expiration date of the voucher is 60 days from the issue date. This program is available for patients with Type 1 diabetes or Type 2 diabetes or gestational diabetes. Patients ages 18 and older are eligible to sign up and receive an offer for the (1) FreeStyle Libre 2 system sensor or (1) FreeStyle Libre 3 system sensor. Patients ages 4-17 are eligible to receive an offer for the (1) FreeStyle Libre 2 sensor or (1) FreeStyle Libre 3 sensor through their parent or guardian. Patients ages 2-17 are eligible to receive an offer for the (1) FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor through their parent or guardian. This offer is void where prohibited by law. Abbott may modify or rescind this offer at any time without notice. The discounts are not available to beneficiaries of Kaiser Permanente, Medicare, Medicaid or other federal or state healthcare programs, residents of Massachusetts, or US territories (other than Puerto Rico). The free (1) FreeStyle Libre 2 system sensor or (1) FreeStyle Libre 3 system sensor is provided as a sample and is limited to one sample per eligible person per product identification number. The FreeStyle Libre 2 system sensor or FreeStyle Libre 3 system sensor cannot be re-sold, traded nor submitted to any third-party payer for reimbursement and is not provided as any inducement for future purchases. The free sample card is not health insurance.

References: 1. Data on file. Abbott Diabetes Care, Inc.  2. Alva, Shridhara, et al. "Accuracy of the third generation of a 14-day continuous glucose monitoring system." Diabetes Therapy 14, no. 4 (2023): 767-776. https://doi.org/10.1007/s13300-023-01385-6. 3. Based on FSL3 User's Manual, Dexcom G7 CGM User Guide, and Medtronic Guardian Connect System User Guide. 4. Dexcom G7 CGM User Guide. 5. Haak, Thomas, et al. "Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated Type 2 diabetes: a multicentre, open-label randomised controlled trial." Diabetes Therapy 8, no. 1 (2017): 55-73. https://doi.org/10.1007/s13300-016-0223-6. 6. Campbell, Fiona M., et al. "Outcomes of using flash glucose monitoring technology by children and young people with Type 1 diabetes in a single arm study." Pediatric Diabetes 19, no. 7 (2018): 1294-1301. https://doi.org/10.1111/pedi.12735. 7. FreeStyle Libre 3 User's Manual. 8. FreeStyle Libre 2 User's Manual. 9. Mowitz, M. Contact Dermatitis (2024): https://doi.org/10.1111/cod.14514.

ADC-36559 v4.0